NEU 1.81% $15.20 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-47

  1. 547 Posts.
    lightbulb Created with Sketch. 468
    Absofreakinlutely- amazing job Jon and Neuren new hope for PMS community
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.